pre-miRNA Information
pre-miRNA hsa-mir-1246   
Genomic Coordinates chr2: 176600980 - 176601052
Synonyms MIRN1246, hsa-mir-1246, MIR1246
Description Homo sapiens miR-1246 stem-loop
Comment None
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-1246
Sequence 11| AAUGGAUUUUUGGAGCAGG |29
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1489969781 2 dbSNP
rs757265617 6 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol ZNF85   
Synonyms HPF4, HTF1
Description zinc finger protein 85
Transcript NM_003429   
Expression
Putative miRNA Targets on ZNF85
3'UTR of ZNF85
(miRNA target sites are highlighted)
>ZNF85|NM_003429|3'UTR
   1 AAATTATGGCAAAGCTTTAATCAATTTACAAGTCTTACTAAACATAAGAAAATTTATACTGGAGAGAAACTACTAACCTG
  81 AAAGATGTGACAATAATTTTGACAACACCTCAGACTTATAAAAGTAATCATACTGGTGAGAAATTCTAAAAATGTGAAGA
 161 CTATGGCAAAGTCTTTAAATGGTTGTCACACTTTAGGTAAGATAATTCATATTGGAACAAACTACAAGTGCAAACAATGT
 241 GGCAAAACTTAATTTATGCTCACACCTTACTGCACAGAAAAGAATTTTTAGTTGAGAAAAAGTATACAAATATAAAGAAT
 321 GTGGAAAAGCCGTTAATATCTGCTCACATCTTACTCAGCATCAGAAAGTACTTAATAAAAGCATTATAAATGGAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' ggacgaggUUUUUAGGUAa 5'
                  :|||| ||:| 
Target 5' agaatgtgGAAAAGCCGTt 3'
316 - 334 103.00 -5.40
2
miRNA  3' ggACGAGGUUUUUAGGuaa 5'
            || |  |:||||:|   
Target 5' acTGGT-GAGAAATTCtaa 3'
132 - 149 96.00 -7.52
3
miRNA  3' ggACGAG---GUUUUUAGGUAa 5'
            ||| |    ||:|||:: | 
Target 5' acTGCACAGAAAAGAATTTTTa 3'
269 - 290 89.00 -6.92
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN13791967 27 COSMIC
COSN30145302 76 COSMIC
COSN20115603 119 COSMIC
COSN30565017 121 COSMIC
COSN30177333 152 COSMIC
COSN20115605 178 COSMIC
COSN20115607 196 COSMIC
COSN6139678 227 COSMIC
COSN23268226 324 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1325350502 4 dbSNP
rs370544885 7 dbSNP
rs1464204273 10 dbSNP
rs373664434 12 dbSNP
rs764516013 16 dbSNP
rs547433359 17 dbSNP
rs56137123 22 dbSNP
rs1019401984 25 dbSNP
rs767919394 32 dbSNP
rs201368631 33 dbSNP
rs1259750347 40 dbSNP
rs1478811352 44 dbSNP
rs751001161 47 dbSNP
rs1347304851 49 dbSNP
rs752274992 49 dbSNP
rs983178061 52 dbSNP
rs907583482 54 dbSNP
rs1475088256 56 dbSNP
rs1191602350 61 dbSNP
rs944872860 67 dbSNP
rs1195476866 73 dbSNP
rs988658469 76 dbSNP
rs1209108748 81 dbSNP
rs1255770906 81 dbSNP
rs1040587832 84 dbSNP
rs536152830 87 dbSNP
rs1020142455 89 dbSNP
rs555745788 92 dbSNP
rs970715078 102 dbSNP
rs1338082222 103 dbSNP
rs1466552530 106 dbSNP
rs569525227 110 dbSNP
rs979451254 117 dbSNP
rs59182323 118 dbSNP
rs538097096 119 dbSNP
rs1292323317 120 dbSNP
rs1412642006 125 dbSNP
rs932252365 130 dbSNP
rs938070662 131 dbSNP
rs557910794 132 dbSNP
rs56339351 136 dbSNP
rs1409276029 140 dbSNP
rs903871774 155 dbSNP
rs55637671 162 dbSNP
rs1037310217 163 dbSNP
rs554157883 164 dbSNP
rs1031097584 167 dbSNP
rs1476346735 168 dbSNP
rs897397834 174 dbSNP
rs1181604275 176 dbSNP
rs35802891 176 dbSNP
rs74192363 176 dbSNP
rs763521613 176 dbSNP
rs896528013 177 dbSNP
rs1196982246 184 dbSNP
rs1272077211 192 dbSNP
rs201500931 192 dbSNP
rs369117648 192 dbSNP
rs1231073842 194 dbSNP
rs1306175243 195 dbSNP
rs1357042067 197 dbSNP
rs28441279 198 dbSNP
rs73021542 202 dbSNP
rs1333855887 203 dbSNP
rs970281751 210 dbSNP
rs759962202 213 dbSNP
rs1027500846 217 dbSNP
rs1341596610 221 dbSNP
rs951723201 221 dbSNP
rs983040073 223 dbSNP
rs907530944 224 dbSNP
rs1199448701 232 dbSNP
rs73021543 233 dbSNP
rs968663529 248 dbSNP
rs1211588342 249 dbSNP
rs1235049911 249 dbSNP
rs114061406 257 dbSNP
rs1251825184 258 dbSNP
rs1211319979 264 dbSNP
rs1336438268 265 dbSNP
rs73021544 271 dbSNP
rs959735318 272 dbSNP
rs577468539 276 dbSNP
rs1348279072 279 dbSNP
rs1281138237 280 dbSNP
rs186952347 283 dbSNP
rs917987626 286 dbSNP
rs1044012417 289 dbSNP
rs970912857 291 dbSNP
rs904069350 294 dbSNP
rs1443237897 303 dbSNP
rs1395432512 307 dbSNP
rs764955272 308 dbSNP
rs1399256790 313 dbSNP
rs1052484064 316 dbSNP
rs1410621894 320 dbSNP
rs73021545 332 dbSNP
rs369562752 333 dbSNP
rs1393837339 336 dbSNP
rs1393271473 341 dbSNP
rs1013700037 343 dbSNP
rs1045536354 348 dbSNP
rs1246857274 357 dbSNP
rs905722145 368 dbSNP
rs942460544 369 dbSNP
rs1240649951 372 dbSNP
rs1040803468 374 dbSNP
rs1301187664 376 dbSNP
rs1001291208 377 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ggacgaGGUUUUUAGGUAa 5'
                ||   ||||||| 
Target 5' ------CCCUUAAUCCAUu 3'
1 - 13
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000328178.8 | 3UTR | CCCUUAAUCCAUUUAACCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE28544 Breast cancer -0.787 2.5e-6 -0.788 2.4e-6 24 Click to see details
GSE42095 Differentiated embryonic stem cells 0.755 1.6e-5 0.688 1.4e-4 23 Click to see details
GSE38974 Chronic obstructive pulmonary disease -0.49 6.5e-3 -0.511 4.5e-3 25 Click to see details
GSE26953 Aortic valvular endothelial cells 0.153 2.4e-1 0.167 2.2e-1 24 Click to see details
GSE28260 Renal cortex and medulla -0.176 2.8e-1 -0.280 1.8e-1 13 Click to see details
GSE38226 Liver fibrosis 0.065 3.9e-1 0.013 4.8e-1 21 Click to see details
GSE32688 Pancreatic cancer 0.001 5.0e-1 0.015 4.7e-1 32 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
HNSC -0.754 0.04 -0.600 0.1 6 Click to see details
HNSC -0.754 0.04 -0.600 0.1 6 Click to see details
HNSC -0.754 0.04 -0.600 0.1 6 Click to see details
52 hsa-miR-1246 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT053774 DYRK1A dual specificity tyrosine phosphorylation regulated kinase 1A 4 1
MIRT196431 TAOK1 TAO kinase 1 2 6
MIRT444394 ZNF480 zinc finger protein 480 2 2
MIRT447596 MSH3 mutS homolog 3 2 2
MIRT454049 TMBIM4 transmembrane BAX inhibitor motif containing 4 2 2
MIRT458257 ZNF85 zinc finger protein 85 2 2
MIRT461493 KIAA1009 centrosomal protein 162 1 1
MIRT474057 LMNB2 lamin B2 2 2
MIRT479231 CKS2 CDC28 protein kinase regulatory subunit 2 2 6
MIRT485663 CHD7 chromodomain helicase DNA binding protein 7 2 2
MIRT485735 CALM2 calmodulin 2 2 2
MIRT498809 SRRT serrate, RNA effector molecule 2 8
MIRT501190 SKIL SKI like proto-oncogene 2 2
MIRT502619 DGS2 DiGeorge syndrome/velocardiofacial syndrome complex 2 2 6
MIRT502665 CTC1 CST telomere replication complex component 1 2 13
MIRT512313 ADCY9 adenylate cyclase 9 2 6
MIRT513756 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 2
MIRT514651 CRADD CASP2 and RIPK1 domain containing adaptor with death domain 2 2
MIRT514865 SHOX2 short stature homeobox 2 2 2
MIRT527109 ARHGAP15 Rho GTPase activating protein 15 2 2
MIRT527145 GPATCH11 G-patch domain containing 11 2 2
MIRT528507 HTR7 5-hydroxytryptamine receptor 7 2 4
MIRT532109 RRP8 ribosomal RNA processing 8 2 2
MIRT534601 RORA RAR related orphan receptor A 2 2
MIRT538906 BRI3BP BRI3 binding protein 2 4
MIRT544541 GDE1 glycerophosphodiester phosphodiesterase 1 2 2
MIRT547430 MED4 mediator complex subunit 4 2 2
MIRT553029 USP48 ubiquitin specific peptidase 48 2 2
MIRT555136 PTPRD protein tyrosine phosphatase, receptor type D 2 2
MIRT562091 KIAA0895 KIAA0895 2 2
MIRT562584 CBX3 chromobox 3 2 4
MIRT563747 ZNF763 zinc finger protein 763 2 2
MIRT573310 AKR7A2 aldo-keto reductase family 7 member A2 2 2
MIRT687232 PLAGL2 PLAG1 like zinc finger 2 2 2
MIRT704465 CREBRF CREB3 regulatory factor 2 2
MIRT718817 PYGO1 pygopus family PHD finger 1 2 2
MIRT731194 NFIB nuclear factor I B 2 1
MIRT732503 SPRED2 sprouty related EVH1 domain containing 2 3 0
MIRT733489 MIF macrophage migration inhibitory factor 2 0
MIRT734071 SRSF1 serine and arginine rich splicing factor 1 2 0
MIRT734733 AR androgen receptor 3 0
MIRT734755 GLS2 glutaminase 2 2 0
MIRT735248 CFTR cystic fibrosis transmembrane conductance regulator 8 1
MIRT736017 ELAVL1 ELAV like RNA binding protein 1 2 0
MIRT736329 DNAH3 dynein axonemal heavy chain 3 2 0
MIRT737381 CCNG2 cyclin G2 2 0
MIRT755524 FOXA2 forkhead box A2 3 1
MIRT755713 DIXDC1 DIX domain containing 1 2 1
MIRT755714 WNT9A Wnt family member 9A 2 1
MIRT755715 RAC2 Rac family small GTPase 2 2 1
MIRT755716 FRAT2 FRAT2, WNT signaling pathway regulator 2 1
MIRT756132 ACE2 angiotensin I converting enzyme 2 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-1 Anthocyanin NULL 145858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Caffeic acid NULL 689043 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Catechin approved 9064 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Curcumin NULL 969516 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Ferulic acid NULL 445858 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Hesperidin NULL 10621 Microarray apoE−/− mice 22253797 2012 up-regulated
miR-1 Quercetin NULL 5280343 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-1 Galactose NULL 6036 Quantitative real-time PCR lens 22736950 2012 up-regulated
miR-1 Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse brain 19270793 2009 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Quantitative real-time PCR myocardial differentiation of mouse ES cells 19521018 2009 down-regulated
miR-1 Sulfonyl-hydrazone-1 (SHZ) NULL NULL Quantitative real-time PCR Murine broblast-derived Induced pluripotent stem cells 21445862 2011 up-regulated
miR-1 Cocaine NULL 446220 Next-generation sequencing ventral striatum 21708909 2011 up-regulated
miR-1 Atorvastatin approved 60823 Quantitative real-time PCR Cardiomyocyte 23860036 2013 down-regualted
miR-1 Glucose NULL 5793 Quantitative real-time PCR endothelial cells 24394957 2014 down-regulated
miR-1 Docosahexaenoic acid NULL 445580 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 Palmitic acid approved 985 Quantitative real-time PCR Caco-2 cells 24623846 2014 up-regulated
miR-1 17beta-estradiol (E2) approved 5757 Microarray MCF-7AKT breast cancer cells 19528081 2009 down-regulated
miR-1 Essential amino acids (EAA) NULL NULL Quantitative real-time PCR skeletal muscle of young adults 19828686 2009 up-regulated
miR-1 Hydrogen peroxide (H2O2) NULL 784 Quantitative real-time PCR Human umbilical vein endothelial cells 21527937 2011 down-regulated
miR-1 Trichostatin A (TSA) NULL 444732 Microarray apoptosis-resistant breast cancer cells 21971930 2011 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-1 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miR-1 Bicalutamide approved 2375 Microarray prostate 22674191 2012 up-regulated
miR-1 Arsenic trioxide approved 14888 Quantitative real-time PCR cardia 22889704 2012 up-regulated
miR-1 Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 up-regulated
miR-1 Quinidine approved 441074 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 up-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR myocardial infarction (MI) rats 19775284 2009 down-regulated
miR-1 Tanshinone IIA NULL 164676 Quantitative real-time PCR post-infarction rat cardiomyocytes 21220930 2011 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 down-regulated
miR-1 Dexamethasone approved 5743 Microarray adrenals and granulosa cells 24205079 2014 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 up-regulated
miR-1 Thiourea (TU) NULL 737139 Quantitative real-time PCR skeletal muscle and heart 22142802 2012 down-regulated
miR-1 Isoproterenol approved 3779 Quantitative real-time PCR heart 22847192 2012 up-regulated
miR-1246 Hydroxycamptothecin (HCPT) NULL 97226 Microarray human Tenon's fibroblasts (HTFs) 24681041 2014 up-regulated
miR-1246 Ascorbate approved 54670067 Microarray Metastatic melanoma cell lines 25202679 2014 up-regualted
miR-1246 5-Fluorouracil approved 3385 Microarray MCF-7 breast cancer cells 21506117 2011 up-regulated
miR-1246 Marine fungal metabolite 1386A NULL NULL Microarray MCF-7 breast cancer cells. 22159329 2012 down-regulated
miR-1246 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 up-regulated
miR-1246 Trastuzumab approved NULL Microarray SKBR3 cells. 22384020 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant High Bladder Cancer cell line (RT4, J82,TCCSUP, UM-UC-3,RT112,CUBIII)
hsa-miR-1246 Oxaliplatin 6857599 NSC266046 approved resistant High Colorectal Cancer cell line (HT-29)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Lung Adenocarcinoma cell line (A549)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant High Gastric Cancer cell line (SGC7901)
hsa-miR-1246 Vincristine 5978 approved resistant High Gastric Cancer cell line (SGC7901)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Pancreatic Cancer cell line (MIA-PaCa-2, PANC-1)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (MIA-PaCa-2, PANC-1)
hsa-miR-1246 Platinum-based doublet chemotherapy sensitive High Lung Adenocarcinoma tissue
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Ductal Adenocarcinoma cell line (BxPC-3)
hsa-miR-1246 Bortezomib 387447 NSC681239 approved resistant High Multiple Myeloma cell line
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Mitoxantrone 4212 NSC279836 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer cell line (MDA-MB-231, MCF-7)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Sorafenib 216239 NSC747971 approved resistant Low Hepatocellular Carcinoma cell line (Hep3B, Huh-7)
hsa-miR-1246 Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant High Gallbladder Cancer cell line (GBC-SD, NOZ)
hsa-miR-1246 Plx-4720 24180719 NSC757438 resistant Low Melanoma cell line (A375P, SK-MEL-2)
hsa-miR-1246 Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Breast Cancer cell line (BCap37, Bads-200, Bats-72)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Epirubicin 41867 NSC256942 approved resistant Low Breast Cancer cell line (MDA-MB-231)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, GNM, OC3, Fadu)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (M14) (1uM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (M14) (1uM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (M14) (200nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (M14) (50nM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (M14) (50nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (WM266) (200nM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (WM266) (200nM)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1246 Trametinib 11707110 NSC758246 approved sensitive High Melanoma cell line (M14) (200nM)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant Low Ovarian Cancer cell line (HeyA8, SKOV3, A2780, THP-1)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant Low Tongue Squamous Cell Carcinoma cell line (CAL-27)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Colorectal Cancer cell line (HCT-116, HCT-8)
hsa-miR-1246 Oxaliplatin 6857599 NSC266046 approved resistant Low Colorectal Cancer cell line (HCT-116, HCT-8)
hsa-miR-1246 Erlotinib 176870 NSC718781 approved sensitive High Head And Neck Squamous Cell Carcinoma cell line (HN6)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved resistant High Breast Cancer cell line (BCap37)
hsa-miR-1246 Trastuzumab resistant Low HER2-Positive Breast Cancer tissue
hsa-miR-1246 Temozolomide 5394 NSC362856 approved sensitive Low Glioblastoma cell line (U87)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant Low Leukemia cell line (K562/ADM and HL-60/RS)
hsa-miR-1246 Fluorouracil 3385 NSC19893 approved resistant Low Melanoma cell line (A375)
hsa-miR-1246 Docetaxel 148124 NSC628503 approved sensitive Low Breast Cancer tissue and cell line (MCF-7, MDA-MB-231, MDA-MB-468, SKBR3)
hsa-miR-1246 Antiepileptic Drug resistant High Pediatric Epilepsy tissue
hsa-mir-1246 Vincristine 5978 approved resistant cell line (W1)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (KYSE)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-mir-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-mir-1246 Decitabine 451668 approved sensitive tissue (esopheageal cancer)
hsa-miR-1246 Temozolomide 5394 NSC362856 approved resistant cell line (U251)
hsa-miR-1246 Gefitinib 123631 NSC715055 approved resistant cell line (PC9)
hsa-miR-1246 Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-1246 Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (CAL-27) (total RNA)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-1246 Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM47)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant cell line (LM11)
hsa-miR-1246 Vemurafenib 42611257 NSC761431 approved resistant cell line (LM36)
hsa-miR-1246 Paclitaxel 36314 NSC125973 approved sensitive cell line (HS578T)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-1246 Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-1246 4-Hydroxytamoxifen+Tamoxifen sensitive cell line (LY2)
hsa-miR-1246 Ethanol+Tamoxifen sensitive cell line (LY2)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-1246 Doxorubicin 31703 NSC123127 approved resistant cell line (K562)
hsa-miR-1246 Platinum-based doublet chemotherapy sensitive tissue (lung adenocarcinoma)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (IGROV-1)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR3)
hsa-miR-1246 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-1246 Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide resistant cell line (Bads-200)
hsa-miR-1246 Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine resistant cell line (Bats-72)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved sensitive cell line (OVSAHO)
hsa-miR-1246 Cisplatin 5460033 NSC119875 approved resistant cell line (TOV-112D)

Error report submission